2020 No. 40
The Carcinogens and Mutagens (Miscellaneous Amendments) Regulations 2020
Made
Laid before Parliament
Coming into force
The Secretary of State, in exercise of the powers conferred by section 2(2) of the European Communities Act 19721, section 15(1) and (2) of, and paragraphs 8(2) and 9 of Schedule 3 to the Health and Safety at Work etc. Act 19742 and sections 85(1), (3) and (7) and 86(1) of the Merchant Shipping Act 19953, makes the following Regulations.
The Secretary of State is a Minister designated4 for the purpose of section 2(2) of the European Communities Act 1972 in relation to measures relating to the safety of ships, and the health and safety of persons in them.
In so far as the following Regulations are made in exercise of powers conferred by sections 15(1) and (2) of the Health and Safety at Work etc. Act 1974, they give effect without modifications to proposals submitted by the Health and Safety Executive under section 11(3) of the 1974 Act5 after carrying out consultation in accordance with section 50(3)6 of that Act.
In so far as the following Regulations are made in exercise of powers conferred by section 85 of the Merchant Shipping Act 1995, the Secretary of State has, in accordance with section 86(4) of the Act, consulted persons in the United Kingdom that the Secretary of State considers will be affected by the proposal to make these Regulations.
Citation and commencement1
These Regulations may be cited as the Carcinogens and Mutagens (Miscellaneous Amendments) Regulations 2020 and come into force on 2nd March 2020.
Interpretation2
In these Regulations, “the 2007 Regulations” means the Merchant Shipping and Fishing Vessels (Health and Safety at Work) (Carcinogens and Mutagens) Regulations 20077.
Amendment of regulation 14 of the 2007 Regulations3
1
Regulation 14 of the 2007 Regulations (health surveillance)8 is amended as follows.
2
After paragraph (4) insert—
4A
Where the doctor or body responsible for the health surveillance of a worker records in that worker’s individual medical record, kept pursuant to paragraph (4), that the health surveillance of the worker should continue after exposure has ended, the worker’s employer must ensure that, while the worker is employed by the employer, the health surveillance of that worker continues for as long as recommended by the doctor or body.
4B
The worker’s employer ceases to be under an obligation to ensure that health surveillance continues for as long as recommended by the doctor or body when a doctor or body responsible for the health surveillance of the worker records in the worker’s individual medical record that this is no longer recommended.
Introduction of a statutory review requirement in the 2007 Regulations4
After regulation 25 (prohibition on levy) of the 2007 Regulations insert—
26Review
1
The Secretary of State must from time to time—
a
carry out a review of the regulatory provision contained in these Regulations, and
b
publish a report setting out the conclusions of the review.
2
The first report must be published before 2nd March 2025.
3
Subsequent reports must be published at intervals not exceeding 5 years.
4
Section 30(4) of the Small Business, Enterprise and Employment Act 20159 requires that a report published under this regulation must, in particular—
a
set out the objectives intended to be achieved by the regulatory provision referred to in paragraph (1)(a),
b
assess the extent to which those objectives are achieved,
c
assess whether those objectives remain appropriate, and
d
if those objectives remain appropriate, assess the extent to which they could be achieved in another way which involves less onerous regulatory provision.
5
In this regulation, “regulatory provision” has the same meaning as in sections 28 to 32 of the Small Business, Enterprise and Employment Act 201510 (see section 32 of that Act).
Amendment of Schedule 1 to the 2007 Regulations5
1
Schedule 1 to the 2007 Regulations (other substances and processes to which the definition of carcinogen relates) is amended as follows.
2
In the list of substances and processes to which the definition of carcinogen relates, after “Hardwood dusts.”, insert—
Work involving exposure to respirable crystalline silica dust generated by a work process.
Amendment of Schedule 2 to the 2007 Regulations6
1
Schedule 2 (table of limit values) is amended as follows.
2
For the table of limit values in Schedule 2, substitute the table in the Schedule to these Regulations.
Amendment of the Mines Regulations 20147
1
The Mines Regulations 201411 are amended as follows.
2
In regulation 2(1) for the definition of “action level” substitute—
“action level” means, in relation to respirable dust, a concentration in air equal to or greater than 3mg/m3 as a time-weighted average over a 40 hour period;
3
Omit regulation 44.
4
In regulation 45—
a
in paragraph (5) omit “and respirable crystalline silica”;
b
in paragraph (6) omit “or respirable crystalline silica”;
c
in paragraph (6)(a) omit “relevant”.
Signed by authority of the Secretary of State for Transport
SCHEDULETable of Limit Values
Name of agent | EC No(1) | CAS No(2) | Limit values(3) | Notation | Transitional measures | ||
---|---|---|---|---|---|---|---|
mg/m3(4) | ppm (5) | f/ml (6) | |||||
Hardwood dusts | — | — | 2 (7) | — | — | — | Limit value 3 mg/m3 until 17 January 2023 |
Chromium (VI) compounds which are carcinogens within the meaning of point (i) of Article 2(a) (as chromium) | — | — | 0,005 | — | — | — | Limit values: 0,025 mg/m3 for welding or plasma cutting processes or similar work processes that generate fume until 17 January 2025, and 0,010 mg/m3 until 17 January 2025 in all other cases |
Refractory ceramic fibres which are carcinogens within the meaning of point (i) of Article 2(a) | — | — | — | — | 0,3 | — | |
Respirable crystalline silica dust | — | — | 0,1 (8) | — | — | — | |
Benzene | 200-753-7 | 71-43-2 | 3,25 | 1 | — | skin (9) | |
Vinyl chloride monomer | 200-831-0 | 75-01-4 | 2,6 | 1 | — | — | |
Ethylene oxide | 200-849-9 | 75-21-8 | 1,8 | 1 | — | skin (9) | |
1,2-Epoxypropane | 200-879-2 | 75-56-9 | 2,4 | 1 | — | — | |
Acrylamide | 201-173-7 | 79-06-1 | 0,1 | — | — | skin (9) | |
2-Nitropropane | 201-209-1 | 79-46-9 | 18 | 5 | — | — | |
o-Toluidine | 202-429-0 | 95-53-4 | 0,5 | 0,1 | — | skin (9) | |
1,3-Butadiene | 203-450-8 | 106-99-0 | 2,2 | 1 | — | — | |
Hydrazine | 206-114-9 | 302-01-2 | 0,013 | 0,01 | — | skin (9) | |
Bromoethylene | 209-800-6 | 593-60-2 | 4,4 | 1 | — | — | |
(1) EC No, i.e. Einecs, ELINCS or NLP, is the official number of the substance within the European Union, as defined in Section 1.1.1.2 in Annex VI, Part 1, to Regulation (EC) No 1272/2008. | |||||||
(2) CAS No: Chemical Abstract Service Registry Number. | |||||||
(3) Measured or calculated in relation to a reference period of eight hours. | |||||||
(4) mg/m3 = milligrams per cubic metre of air at 20 °C and 101,3 kPa (760 mm mercury pressure). | |||||||
(5) ppm = parts per million by volume in air (ml/m3). | |||||||
(6) f/ml = fibres per millilitre. | |||||||
(7) Inhalable fraction: if hardwood dusts are mixed with other wood dusts, the limit value shall apply to all wood dusts present in that mixture. | |||||||
(8) Respirable fraction. | |||||||
(9) Substantial contribution to the total body burden via dermal exposure possible. |
(This note is not part of the Regulations)